Valuation: StimCell Energetics Inc.

Market Cap 4.04M 3.46M 3.24M 2.96M 5.56M 386M 5.63M 38.23M 14.91M 194M 15.16M 14.83M 642M P/E 2026 *
-4.77x
P/E 2027 * -9.55x
Enterprise Value 4.84M 4.14M 3.88M 3.55M 6.66M 463M 6.75M 45.81M 17.86M 233M 18.16M 17.77M 769M EV / Sales 2026 *
-
EV / Sales 2027 * -
Free-Float
28.33%
Yield 2026 *
-
Yield 2027 * -
1 day+6.09%
1 week-36.33%
Current month-32.03%
1 month-30.80%
3 months-34.14%
6 months-38.28%
Current year-52.25%
1 week 0.18
Extreme 0.18
0.3
1 month 0.18
Extreme 0.18
0.35
Current year 0.18
Extreme 0.18
0.48
1 year 0.18
Extreme 0.18
0.48
3 years 0
Extreme 0.0015
3.42
5 years 0
Extreme 1.4E-5
13.97
10 years 0
Extreme 1.4E-5
25.35
Manager TitleAgeSince
Chief Executive Officer 56 11/12/2023
Director of Finance/CFO 48 23/11/2014
Director TitleAgeSince
Chairman 78 25/02/2024
Director/Board Member 62 07/06/2020
Director/Board Member 56 11/12/2023
Date Insider Type Main position Quantity % Market Cap.
18/12/25 Sell

Director

16,667 0.0807%
17/03/25 Tax

Director

60,841,472 307.0278%
25/02/25 Buy 15,000 0.0757%
Change 5-day change 1-year change 3-year change Capi.($)
+6.09%-36.33%-29.26%-57.56% 4.04M
+1.09%+5.26%+4.52%+26.24% 51.61B
-1.07%+2.82%+465.96%+586.75% 44.89B
+1.47%+9.79%+35.92%+21.40% 42.77B
+1.44%+7.77%+19.38%+92.75% 42.58B
-0.93%-4.33%+16.18%+53.76% 31.82B
+1.32%+7.30%+33.89%+150.10% 17.33B
-0.60%+1.93% - - 16.63B
+0.03%+3.41%+6.55%+32.10% 14.76B
+1.28%+5.41%+82.40%+47.43% 14.09B
Average +1.01%+3.99%+70.61%+105.89% 27.65B
Weighted average by Cap. +0.49%+4.72%+99.57%+146.29%

Financials

2026 *2027 *
Net sales - -
Net income -792M -679M -635M -581M -1.09B -75.82B -1.11B -7.5B -2.93B -38.09B -2.98B -2.91B -126B -510M -437M -409M -374M -702M -48.8B -712M -4.83B -1.88B -24.51B -1.91B -1.87B -81.08B
Net Debt 800K 685K 641K 587K 1.1M 76.54M 1.12M 7.58M 2.95M 38.45M 3M 2.94M 127M 800K 685K 641K 587K 1.1M 76.54M 1.12M 7.58M 2.95M 38.45M 3M 2.94M 127M
Logo StimCell Energetics Inc.
StimCell Energetics Inc. is a biotech company, which is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System. eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms through the epidermis at the touch of a button to help you gain optimal wellness and reduce pain. Its eBalance represents a monumental stride in the realm of medical technology designed to rejuvenate and re-energize the human body at a cellular level. The operation of eBalance is an intricate process of precision engineering and human biology.
Employees
1
Date Price Change Volume
21/08/26 US$0.1910 +6.09% 1,071
20/08/26 US$0.1800 -8.35% 11,594
19/08/26 US$0.1964 -10.07% 12,001

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STME Stock